Robert Davis is Chairman, Chief Executive Officer and President of Merck & Co., Inc. (MRK). The company reported total compensation of $20,797,845 for fiscal year 2025.
| Salary | $1,645,302 |
|---|---|
| Bonus | $0 |
| Stock awards | $12,102,838 |
| Option awards | $3,380,004 |
| Non-equity incentive plan | $2,326,500 |
| Pension and non-qualified deferred compensation | $685,143 |
| All other compensation | $658,058 |
| Total | $20,797,845 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Merck & Co., Inc. filed April 8, 2026, accession 0001193125-26-147704.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman, Chief Executive Officer and President | $1,645,302 | $0 | $12,102,838 | $3,380,004 | $2,326,500 | $685,143 | $658,058 | $20,797,845 |
| FY2024 | Chairman, Chief Executive Officer and President | $1,623,874 | $0 | $13,077,541 | $4,650,010 | $2,761,650 | $511,878 | $561,112 | $23,186,064 |
| FY2023 | Chairman, Chief Executive Officer and President | $1,603,091 | $0 | $9,997,585 | $4,050,000 | $3,585,300 | $651,163 | $386,148 | $20,273,287 |
| FY2022 | Chairman, Chief Executive Officer and President | $1,538,613 | $0 | $8,868,587 | $3,524,995 | $4,125,150 | $180,259 | $412,490 | $18,650,093 |
| FY2021 | Chief Executive Officer, President and Former Chief Financial Officer | $1,319,959 | $0 | $6,324,576 | $2,760,003 | $2,834,606 | $235,640 | $247,337 | $13,722,121 |
| FY2020 | Chief Executive Officer, President and Former Chief Financial Officer | $1,112,795 | $0 | $2,737,406 | $1,199,772 | $1,018,194 | $611,948 | $159,395 | $6,839,510 |
Totals as disclosed in each year's own compensation disclosure for Merck & Co., Inc..
| Peer-group chief executive median | $28,437,198 |
|---|---|
| Difference from that median | $-7,639,353 |
| Percentile within the disclosed peer group | 1st |
| Peers with a disclosed figure | 7 |
Medians and percentiles are computed across the peer group Merck & Co., Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Robert Davis this page | Chairman, Chief Executive Officer and President | $20,797,845 |
| Dean Li | Executive Vice President and President, Merck Research Laboratories | $8,892,881 |
| Caroline Litchfield | Executive Vice President and Chief Financial Officer | $7,514,085 |
| Jennifer Zachary | Executive Vice President and General Counsel | $5,860,578 |
| Sanat Chattopadhyay | Executive Vice President and President, Merck Manufacturing Division | $5,408,408 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Merck & Co., Inc. compensation brief.
Robert Davis's compensation sits inside Merck & Co., Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.